- Home
- XNET vs KMDA Comparison
XNET vs KMDA Comparison
Compare XNET & KMDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XNET
- KMDA
- Stock Information
- Founded
- XNET 2003
- KMDA 1990
- Country
- XNET China
- KMDA Israel
- Employees
- XNET N/A
- KMDA N/A
- Industry
- XNET Computer Software: Prepackaged Software
- KMDA Biotechnology: Pharmaceutical Preparations
- Sector
- XNET Technology
- KMDA Health Care
- Exchange
- XNET Nasdaq
- KMDA Nasdaq
- Market Cap
- XNET 373.0M
- KMDA 430.1M
- IPO Year
- XNET 2014
- KMDA N/A
- Fundamental
- Price
- XNET $7.23
- KMDA $6.92
- Analyst Decision
- XNET
- KMDA Strong Buy
- Analyst Count
- XNET 0
- KMDA 2
- Target Price
- XNET N/A
- KMDA $13.00
- AVG Volume (30 Days)
- XNET 1.7M
- KMDA 49.8K
- Earning Date
- XNET 08-14-2025
- KMDA 08-13-2025
- Dividend Yield
- XNET N/A
- KMDA 2.89%
- EPS Growth
- XNET 5056.12
- KMDA 27.97
- EPS
- XNET 11.50
- KMDA 0.32
- Revenue
- XNET $355,826,000.00
- KMDA $169,517,000.00
- Revenue This Year
- XNET N/A
- KMDA $14.49
- Revenue Next Year
- XNET N/A
- KMDA $10.12
- P/E Ratio
- XNET $0.63
- KMDA $21.11
- Revenue Growth
- XNET 11.15
- KMDA 9.67
- 52 Week Low
- XNET $1.51
- KMDA $5.17
- 52 Week High
- XNET $8.80
- KMDA $9.16
- Technical
- Relative Strength Index (RSI)
- XNET 63.14
- KMDA 40.06
- Support Level
- XNET $6.54
- KMDA $6.97
- Resistance Level
- XNET $7.37
- KMDA $7.28
- Average True Range (ATR)
- XNET 0.57
- KMDA 0.20
- MACD
- XNET 0.05
- KMDA -0.02
- Stochastic Oscillator
- XNET 64.48
- KMDA 1.69
About XNET Xunlei Limited
Xunlei Ltd is a cloud-based acceleration technology company in China. The company operates a powerful internet platform in China based on cloud computing to provide users with quick and easy access to digital media content through its products and services, Xunlei Accelerator, and cloud acceleration subscription services. It is increasingly extending into mobile devices in part through potentially pre-installed acceleration products in mobile phones Xunlei has developed various value-added services to meet a fuller spectrum of its users' digital media content access and consumption needs.
About KMDA Kamada Ltd.
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.